CUSIP: 85858C107
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,017,206
-
Share change
-
-176,571
-
Total reported value
-
$67,810,933
-
Put/Call ratio
-
0%
-
Price per share
-
$6.77
-
Number of holders
-
57
-
Value change
-
-$922,678
-
Number of buys
-
23
-
Number of sells
-
24
Quarterly Holders Quick Answers
What is CUSIP 85858C107?
CUSIP 85858C107 identifies STML - STEMLINE THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2016
-
Previous quarter:
Q1 2016
Recent filing periods for CUSIP 85858C107:
Institutional Holders of STEMLINE THERAPEUTICS INC - COM (STML) as of Q2 2016
As of 30 Jun 2016,
STEMLINE THERAPEUTICS INC - COM (STML) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,017,206 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, TimesSquare Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BAKER BROS. ADVISORS LP, VHCP Management II, LLC, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This page lists
57
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.